| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | carbonate dehydratase activity | 1.64e-04 | 16 | 24 | 2 | GO:0004089 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 3.68e-04 | 1189 | 24 | 7 | GO:0046914 | |
| GeneOntologyMolecularFunction | zinc ion binding | 5.23e-04 | 891 | 24 | 6 | GO:0008270 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 1.98e-03 | 55 | 24 | 2 | GO:0008146 | |
| GeneOntologyMolecularFunction | hydro-lyase activity | 2.59e-03 | 63 | 24 | 2 | GO:0016836 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 2.75e-03 | 65 | 24 | 2 | GO:0016706 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 3.55e-03 | 74 | 24 | 2 | GO:0016782 | |
| GeneOntologyMolecularFunction | carbon-oxygen lyase activity | 4.34e-03 | 82 | 24 | 2 | GO:0016835 | |
| GeneOntologyMolecularFunction | myosin binding | 4.65e-03 | 85 | 24 | 2 | GO:0017022 | |
| GeneOntologyMolecularFunction | dioxygenase activity | 6.13e-03 | 98 | 24 | 2 | GO:0051213 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | 8.86e-03 | 1099 | 24 | 5 | GO:0008092 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 9.71e-03 | 372 | 24 | 3 | GO:0061630 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 1.17e-02 | 398 | 24 | 3 | GO:0061659 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 1.29e-02 | 775 | 24 | 4 | GO:0016746 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular pH reduction | 1.29e-05 | 5 | 24 | 2 | GO:0032849 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, GABAergic | 1.90e-05 | 45 | 24 | 3 | GO:0032228 | |
| GeneOntologyBiologicalProcess | regulation of chloride transport | 2.72e-05 | 7 | 24 | 2 | GO:2001225 | |
| GeneOntologyBiologicalProcess | regulation of cellular pH reduction | 3.62e-05 | 8 | 24 | 2 | GO:0032847 | |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 8.50e-05 | 74 | 24 | 3 | GO:0051932 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic anion transport | 1.96e-04 | 18 | 24 | 2 | GO:0044070 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, GABAergic | 2.43e-04 | 20 | 24 | 2 | GO:0032230 | |
| HumanPheno | Abnormal concentration of calcium in blood | 1.41e-05 | 162 | 6 | 4 | HP:0040077 | |
| HumanPheno | Abnormal circulating calcium concentration | 3.32e-05 | 201 | 6 | 4 | HP:0004363 | |
| HumanPheno | Abnormal blood inorganic cation concentration | 4.41e-05 | 216 | 6 | 4 | HP:0010927 | |
| HumanPheno | Hypocalcemia | 8.96e-05 | 86 | 6 | 3 | HP:0002901 | |
| Domain | Carbonic_anhydrase_a-class_CS | 1.04e-04 | 12 | 24 | 2 | IPR018338 | |
| Domain | Carbonic_anhydrase_a-class | 1.64e-04 | 15 | 24 | 2 | IPR023561 | |
| Domain | ALPHA_CA_1 | 1.64e-04 | 15 | 24 | 2 | PS00162 | |
| Domain | Carb_anhydrase | 2.13e-04 | 17 | 24 | 2 | PF00194 | |
| Domain | Carb_anhydrase | 2.13e-04 | 17 | 24 | 2 | SM01057 | |
| Domain | - | 2.13e-04 | 17 | 24 | 2 | 3.10.200.10 | |
| Domain | Carbonic_anhydrase_a | 2.13e-04 | 17 | 24 | 2 | IPR001148 | |
| Domain | ALPHA_CA_2 | 2.13e-04 | 17 | 24 | 2 | PS51144 | |
| Domain | ATP_grasp_subdomain_2 | 7.19e-04 | 31 | 24 | 2 | IPR013816 | |
| Domain | - | 2.39e-03 | 449 | 24 | 4 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 2.59e-03 | 459 | 24 | 4 | IPR013083 | |
| Domain | ConA-like_dom | 2.68e-03 | 219 | 24 | 3 | IPR013320 | |
| Domain | Zinc_finger_PHD-type_CS | 3.13e-03 | 65 | 24 | 2 | IPR019786 | |
| Domain | BBOX | 3.52e-03 | 69 | 24 | 2 | SM00336 | |
| Domain | Butyrophylin | 3.62e-03 | 70 | 24 | 2 | IPR003879 | |
| Domain | - | 3.73e-03 | 71 | 24 | 2 | 4.10.45.10 | |
| Domain | zf-B_box | 3.83e-03 | 72 | 24 | 2 | PF00643 | |
| Domain | Znf_PHD-finger | 4.59e-03 | 79 | 24 | 2 | IPR019787 | |
| Domain | ZF_BBOX | 4.70e-03 | 80 | 24 | 2 | PS50119 | |
| Domain | Znf_B-box | 4.82e-03 | 81 | 24 | 2 | IPR000315 | |
| Domain | SPRY | 5.54e-03 | 87 | 24 | 2 | SM00449 | |
| Domain | PHD | 5.79e-03 | 89 | 24 | 2 | SM00249 | |
| Domain | Znf_PHD | 6.04e-03 | 91 | 24 | 2 | IPR001965 | |
| Domain | SPRY | 6.44e-03 | 94 | 24 | 2 | PF00622 | |
| Domain | SPRY_dom | 6.44e-03 | 94 | 24 | 2 | IPR003877 | |
| Domain | ZF_PHD_2 | 6.57e-03 | 95 | 24 | 2 | PS50016 | |
| Domain | B30.2/SPRY | 6.57e-03 | 95 | 24 | 2 | IPR001870 | |
| Domain | B302_SPRY | 6.57e-03 | 95 | 24 | 2 | PS50188 | |
| Domain | ZF_PHD_1 | 6.70e-03 | 96 | 24 | 2 | PS01359 | |
| Domain | RING | 6.77e-03 | 305 | 24 | 3 | SM00184 | |
| Domain | PROTEIN_KINASE_TYR | 6.84e-03 | 97 | 24 | 2 | PS00109 | |
| Domain | Tyr_kinase_AS | 6.84e-03 | 97 | 24 | 2 | IPR008266 | |
| Domain | Znf_RING | 8.13e-03 | 326 | 24 | 3 | IPR001841 | |
| Domain | Cadherin | 9.98e-03 | 118 | 24 | 2 | IPR002126 | |
| Pathway | REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE | 8.97e-05 | 12 | 17 | 2 | MM14574 | |
| Pathway | REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE | 8.97e-05 | 12 | 17 | 2 | M671 | |
| Pathway | KEGG_NITROGEN_METABOLISM | 3.41e-04 | 23 | 17 | 2 | M4629 | |
| Pubmed | Neuronal carbonic anhydrase VII provides GABAergic excitatory drive to exacerbate febrile seizures. | 4.56e-07 | 2 | 24 | 2 | 23881097 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 37895185 | ||
| Pubmed | Carbonic anhydrase enzymes II, VII, IX and XII in colorectal carcinomas. | 2.74e-06 | 4 | 24 | 2 | 27688658 | |
| Pubmed | Human carbonic anhydrases and carbonic anhydrase deficiencies. | 4.56e-06 | 5 | 24 | 2 | 7574487 | |
| Pubmed | 1.27e-05 | 8 | 24 | 2 | 20820888 | ||
| Pubmed | A systematic quantification of carbonic anhydrase transcripts in the mouse digestive system. | 3.00e-05 | 12 | 24 | 2 | 17362527 | |
| Pubmed | 7.75e-05 | 19 | 24 | 2 | 19767753 | ||
| Pubmed | TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity. | 7.75e-05 | 19 | 24 | 2 | 26347139 | |
| Pubmed | 8.61e-05 | 20 | 24 | 2 | 20564319 | ||
| Pubmed | A systematic survey of carbonic anhydrase mRNA expression during mammalian inner ear development. | 1.05e-04 | 22 | 24 | 2 | 23233153 | |
| Pubmed | Image-based genome-wide siRNA screen identifies selective autophagy factors. | 1.77e-04 | 159 | 24 | 3 | 22020285 | |
| Pubmed | 2.10e-04 | 31 | 24 | 2 | 15217342 | ||
| Pubmed | 2.68e-04 | 35 | 24 | 2 | 11013070 | ||
| Pubmed | Identification of UHRF1/2 as new N-methylpurine DNA glycosylase-interacting proteins. | 3.16e-04 | 38 | 24 | 2 | 23537643 | |
| Pubmed | 3.16e-04 | 38 | 24 | 2 | 11779826 | ||
| Cytoband | 7q11.23 | 1.18e-03 | 97 | 24 | 2 | 7q11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | 8.80e-03 | 271 | 24 | 2 | chr7q11 | |
| GeneFamily | Carbonic anhydrases | 1.76e-04 | 18 | 20 | 2 | 460 | |
| GeneFamily | PHD finger proteins | 4.39e-03 | 90 | 20 | 2 | 88 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 4.88e-03 | 95 | 20 | 2 | 59 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.35e-02 | 161 | 20 | 2 | 593 | |
| GeneFamily | WD repeat domain containing | 3.35e-02 | 262 | 20 | 2 | 362 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-06 | 176 | 24 | 4 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-06 | 176 | 24 | 4 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.37e-06 | 178 | 24 | 4 | 0139b42494c1186390b12106dea7957e2b6717c2 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.68e-06 | 199 | 24 | 4 | e9c83555d2197b740797a9f33b64f8f7a7ba1ee2 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-MEP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.33e-05 | 137 | 24 | 3 | 0bb5cccc31e7c44d44a2db3f59b68f9a81503151 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.26e-05 | 165 | 24 | 3 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.26e-05 | 165 | 24 | 3 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.26e-05 | 165 | 24 | 3 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.43e-05 | 166 | 24 | 3 | ec719368295133da2f7ff587c5329ed6db1dd56d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.43e-05 | 166 | 24 | 3 | 8e2faca6a2e76a625de04d6098aa6f98911945c6 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 9.77e-05 | 168 | 24 | 3 | 8697b40b2ec2cce68ef3beb4792eb3eff29be053 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 9.94e-05 | 169 | 24 | 3 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 1.01e-04 | 170 | 24 | 3 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-04 | 170 | 24 | 3 | af8b56555cbd5a1016ab9ec2ce88225c58c89648 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 171 | 24 | 3 | 4e856441063e9825b6f87a1d3dd19c77dae4662c | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-04 | 172 | 24 | 3 | 9a1743abcd5fbd38253ea84d88ad716cfb71de36 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 174 | 24 | 3 | 3d4c05ea5719ca65e85d1f15198453034791087c | |
| ToppCell | COVID-19-Myeloid-MoAM4|COVID-19 / Condition, Lineage and Cell class | 1.14e-04 | 177 | 24 | 3 | ca5d0c3d5c700bbe4c2da068eb02be6229afb9a0 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-chondrocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.14e-04 | 177 | 24 | 3 | 915b848d789051a1c3bc6f6dc86955bb752276ab | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 178 | 24 | 3 | 5f779a66aa42d1d8e8af17b4a08d5dcc733efd4c | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 179 | 24 | 3 | dfd9d29281510d32f1a2e8336d2e58ef496cfd1d | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.18e-04 | 179 | 24 | 3 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.18e-04 | 179 | 24 | 3 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.20e-04 | 180 | 24 | 3 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | Mesenchymal_cells-Chondrocytes|Mesenchymal_cells / Lineage and Cell class | 1.20e-04 | 180 | 24 | 3 | 6e399368430ef3afa9ce1ef0ed90f614ccef9987 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-04 | 182 | 24 | 3 | bb7de0c93d8f59f13c990e425139b9348ca8027e | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular-Chondrocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-04 | 182 | 24 | 3 | 507f095af4dff60f2c2b64d750477154084c3595 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-04 | 182 | 24 | 3 | 88bd17c07bd8443a0ede4e9dc7bc9d1230b42211 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 182 | 24 | 3 | c4a7007c864a9455a7e7447e28ccd380878a6a0f | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 182 | 24 | 3 | c315d820ffad912c014ba5eac6f5fa6de1a94384 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 183 | 24 | 3 | b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 184 | 24 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 184 | 24 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 184 | 24 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 1.28e-04 | 184 | 24 | 3 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-04 | 185 | 24 | 3 | 241ea1e178fffef9e7df971de739e794332d5173 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.30e-04 | 185 | 24 | 3 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.32e-04 | 186 | 24 | 3 | 80a0a42ca8585cdb1dda57a18c254316a126ee64 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.34e-04 | 187 | 24 | 3 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-04 | 187 | 24 | 3 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 1.36e-04 | 188 | 24 | 3 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 189 | 24 | 3 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 189 | 24 | 3 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 190 | 24 | 3 | bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690 | |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-04 | 190 | 24 | 3 | d541e076137cf7334bdb0ed69db2f9a27c668c65 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 190 | 24 | 3 | 3b8d1e66ae68c1eee64095e75195d76d97e24026 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 190 | 24 | 3 | dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 191 | 24 | 3 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 191 | 24 | 3 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 191 | 24 | 3 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.43e-04 | 191 | 24 | 3 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 192 | 24 | 3 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 192 | 24 | 3 | bacbaef1f230051335f4433e55db07a161b96b4c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 192 | 24 | 3 | 3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91 | |
| ToppCell | (3)_Chondrocytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.45e-04 | 192 | 24 | 3 | 5d2b4830d025d3dbdf5623ce1c28d1036e1984a8 | |
| ToppCell | 11.5-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 1.47e-04 | 193 | 24 | 3 | d4779d92a4dd4b8b656383e6f4fce76d3bd70931 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 193 | 24 | 3 | 6a623acd1adad9a78eddc32ffedb16352ad3fdfa | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 193 | 24 | 3 | daefbfd3a3dd1351fbe94b9abfd807db44d56c24 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-DC2|Lung / Manually curated celltypes from each tissue | 1.47e-04 | 193 | 24 | 3 | c97f9b13057f803df63c696c6175ef8e0aba6fa7 | |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-04 | 194 | 24 | 3 | 11ff53a748160570d2908ea9eb9779c038e5b676 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-04 | 194 | 24 | 3 | a429d22c8c9d0fd3bfa9f877a6364cecad68db30 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-04 | 194 | 24 | 3 | b0c15e7e4bcf30856fb628dedd7ba82df33489f5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 195 | 24 | 3 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 195 | 24 | 3 | d35102f95bb1e419d2df05ff0a01b6c5c923acef | |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-04 | 195 | 24 | 3 | 9231e929657542b78a6480d44402866511129c7f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 196 | 24 | 3 | 48b4a9cea97a55190217deaf51bf867608c5a9a7 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 1.54e-04 | 196 | 24 | 3 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 196 | 24 | 3 | 473980c827443464d08a0be28c53e3536369b12a | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.54e-04 | 196 | 24 | 3 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 196 | 24 | 3 | 8f2031b1a9232c389517fbf3c29f47f9468b0077 | |
| ToppCell | distal-Endothelial-Vein-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.56e-04 | 197 | 24 | 3 | 3d71c93da4b88ebbd58e68ed3dbf610d4bcfc4f5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 197 | 24 | 3 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.56e-04 | 197 | 24 | 3 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 197 | 24 | 3 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.56e-04 | 197 | 24 | 3 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | ASK428-Endothelial|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.59e-04 | 198 | 24 | 3 | d69d0ff115298596173a4278897a65007a71f5df | |
| ToppCell | distal-1-Endothelial-Vein|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.59e-04 | 198 | 24 | 3 | eee6cb4fe0e1caf460869d5a0a57c9d259573f10 | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic-Chondrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-04 | 198 | 24 | 3 | 55f013e9e6587d9ece59751fa131b1d22d6cceea | |
| ToppCell | distal-Endothelial-Artery-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.59e-04 | 198 | 24 | 3 | f284f59f4ebe55ee132eddfaa2f5d9ecb059654f | |
| ToppCell | (2)_Fibroblasts-(23)_Fibro-4|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.59e-04 | 198 | 24 | 3 | e0ef49ec0f87cc87b45efa297b9ff6c35b7a2ba9 | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-04 | 198 | 24 | 3 | c72ef2ddcbb6dacbed4c6200d89e17d57314dcdc | |
| ToppCell | 18-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 1.61e-04 | 199 | 24 | 3 | f5d0aa4170367c080d3c2f01d9af3529762917fa | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-04 | 199 | 24 | 3 | 0075bcc7d2a5031e76a24cb176e16ac998d846fd | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | 96540be0e906bbc626049a41978be3dc051d2024 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | ac6b8bc9998d303f788511b8f111e682ea9f3df8 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | 8943278190f42016ee914e584d1b6b9aeaf7c73f | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | 41d7736427494cb30a2f23722ea2b86ff308cfd8 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | proximal-mesenchymal-Fibromyocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.63e-04 | 200 | 24 | 3 | 37d9f46f727a31e8e94e348e4ddd71a2125ba01a | |
| ToppCell | proximal-3-mesenchymal-Fibromyocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.63e-04 | 200 | 24 | 3 | ed6fbe61a04d29b105054f7058abe7469314b304 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | proximal-mesenchymal-Fibromyocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.63e-04 | 200 | 24 | 3 | 49658e1b530de0dad16d45a1112bdf5329bb800d | |
| ToppCell | Neuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | 5ef4a3dc18a44292184a59ced916183c0699b01e | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | ea52df18400550b65de142d03b3b0963436e03d9 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-03 | 93 | 24 | 2 | 6d91b52147fb68461b39223e52026f2a02dcda7f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-03 | 93 | 24 | 2 | d6409351d89f6289411bac4aff65322e91212e57 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-03 | 93 | 24 | 2 | d736a59d48fa0dc41afef67f1a1507105558e47c | |
| Computational | Genes in the cancer module 560. | 1.54e-04 | 12 | 17 | 2 | MODULE_560 | |
| Computational | Genes in the cancer module 465. | 2.79e-04 | 16 | 17 | 2 | MODULE_465 | |
| Computational | AA biosynthesis. | 3.55e-04 | 18 | 17 | 2 | MODULE_354 | |
| Drug | ipsl | 1.06e-05 | 5 | 24 | 2 | CID000161551 | |
| Drug | EMD 486019 | 1.59e-05 | 6 | 24 | 2 | CID011245700 | |
| Drug | orthanilamide | 1.59e-05 | 6 | 24 | 2 | CID000072894 | |
| Drug | 2h15 | 1.59e-05 | 6 | 24 | 2 | CID010712038 | |
| Drug | L-662,583 | 2.97e-05 | 8 | 24 | 2 | CID003082977 | |
| Drug | L-643,799 | 2.97e-05 | 8 | 24 | 2 | CID000121595 | |
| Drug | sezolamide | 2.97e-05 | 8 | 24 | 2 | CID000060692 | |
| Drug | aminozolamide | 2.97e-05 | 8 | 24 | 2 | CID000093505 | |
| Drug | qassa | 3.82e-05 | 9 | 24 | 2 | CID003082191 | |
| Drug | 6-hydroxyethoxzolamide | 3.82e-05 | 9 | 24 | 2 | CID000094706 | |
| Drug | Chlorzoxazone [95-25-0]; Up 200; 23.6uM; PC3; HT_HG-U133A | 4.75e-05 | 194 | 24 | 4 | 2100_UP | |
| Drug | Prontosil | 4.77e-05 | 10 | 24 | 2 | CID000066895 | |
| Drug | 1,3-benzenedisulfonamide | 4.77e-05 | 10 | 24 | 2 | CID003090044 | |
| Drug | metanilamide | 4.77e-05 | 10 | 24 | 2 | CID000007377 | |
| Drug | Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 5.04e-05 | 197 | 24 | 4 | 7350_DN | |
| Drug | cobalt phosphate | 5.82e-05 | 11 | 24 | 2 | CID000061615 | |
| Drug | Cl 13850 | 5.82e-05 | 11 | 24 | 2 | CID000159459 | |
| Drug | STX64 | 5.82e-05 | 11 | 24 | 2 | CID005287541 | |
| Drug | Tio-urasin | 5.82e-05 | 11 | 24 | 2 | CID000084724 | |
| Drug | hydroflumethiazide | 6.98e-05 | 12 | 24 | 2 | CID000003647 | |
| Drug | chlorzolamide | 8.25e-05 | 13 | 24 | 2 | CID000165323 | |
| Drug | Fg 400 | 8.25e-05 | 13 | 24 | 2 | CID000012443 | |
| Drug | mafenide acetate | 8.25e-05 | 13 | 24 | 2 | CID000003998 | |
| Drug | cobalt;sulfide | 9.62e-05 | 14 | 24 | 2 | CID000159453 | |
| Drug | metolazone | 1.43e-04 | 17 | 24 | 2 | CID000004170 | |
| Drug | apraclonidine | 1.61e-04 | 18 | 24 | 2 | CID000002216 | |
| Drug | sulthiame | 1.80e-04 | 19 | 24 | 2 | CID000005356 | |
| Drug | AC1LCVB4 | 2.21e-04 | 21 | 24 | 2 | CID000656627 | |
| Drug | AABSSN | 2.43e-04 | 22 | 24 | 2 | CID005464134 | |
| Drug | tuo | 2.66e-04 | 23 | 24 | 2 | CID014611919 | |
| Drug | dichlorphenamide | 2.66e-04 | 23 | 24 | 2 | CID000003038 | |
| Drug | potassium cyanate | 2.90e-04 | 24 | 24 | 2 | CID011378442 | |
| Drug | methazolamide | 3.41e-04 | 26 | 24 | 2 | CID000004100 | |
| Drug | benzolamide | 3.96e-04 | 28 | 24 | 2 | CID000018794 | |
| Drug | thiadiazole | 4.25e-04 | 29 | 24 | 2 | CID000067518 | |
| Drug | Zinc chromate hydroxide | 4.25e-04 | 29 | 24 | 2 | CID000027567 | |
| Drug | sulfamide | 4.86e-04 | 31 | 24 | 2 | CID000082267 | |
| Drug | dimethadione | 5.18e-04 | 32 | 24 | 2 | CID000003081 | |
| Drug | MZ-m | 5.51e-04 | 33 | 24 | 2 | CID000001798 | |
| Drug | benzenesulfonamide | 5.51e-04 | 33 | 24 | 2 | CID000007370 | |
| Drug | ebrotidine | 5.85e-04 | 34 | 24 | 2 | CID000065869 | |
| Drug | chlorthalidone | 6.56e-04 | 36 | 24 | 2 | CID000002732 | |
| Drug | bendrofluazide | 7.71e-04 | 39 | 24 | 2 | CID000002315 | |
| Drug | indisulam | 7.71e-04 | 39 | 24 | 2 | CID000216468 | |
| Drug | brinzolamide | 8.11e-04 | 40 | 24 | 2 | CID000068844 | |
| Drug | ethoxzolamide | 8.11e-04 | 40 | 24 | 2 | CID000003295 | |
| Drug | azide | 8.70e-04 | 180 | 24 | 3 | CID000033558 | |
| Drug | DB08219 | 9.81e-04 | 44 | 24 | 2 | CID011840966 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 9.87e-04 | 188 | 24 | 3 | 5596_UP | |
| Drug | Lansoprazole [103577-45-3]; Down 200; 10.8uM; HL60; HT_HG-U133A | 1.00e-03 | 189 | 24 | 3 | 2967_DN | |
| Drug | thapsigargin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.02e-03 | 190 | 24 | 3 | 7053_DN | |
| Drug | Thiostrepton [1393-48-2]; Up 200; 2.4uM; PC3; HT_HG-U133A | 1.02e-03 | 190 | 24 | 3 | 4563_UP | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.03e-03 | 191 | 24 | 3 | 5327_UP | |
| Drug | Monobenzone [103-16-2]; Down 200; 20uM; HL60; HT_HG-U133A | 1.05e-03 | 192 | 24 | 3 | 3054_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.05e-03 | 192 | 24 | 3 | 2450_DN | |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 6.06e-05 | 15 | 23 | 2 | DOID:1928 (implicated_via_orthology) | |
| Disease | protein C measurement | 7.85e-05 | 17 | 23 | 2 | EFO_0004633 | |
| Disease | uric acid measurement | 9.18e-05 | 610 | 23 | 5 | EFO_0004761 | |
| Disease | anthropometric measurement | 2.95e-04 | 168 | 23 | 3 | EFO_0004302 | |
| Disease | body fat percentage | 5.10e-04 | 488 | 23 | 4 | EFO_0007800 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 1.77e-03 | 80 | 23 | 2 | DOID:1459 (biomarker_via_orthology) | |
| Disease | age-related macular degeneration | 2.18e-03 | 89 | 23 | 2 | EFO_0001365 | |
| Disease | Squamous cell carcinoma of esophagus | 2.48e-03 | 95 | 23 | 2 | C0279626 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.75e-03 | 364 | 23 | 3 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | Liver Cirrhosis | 2.91e-03 | 103 | 23 | 2 | C0023890 | |
| Disease | Fibrosis, Liver | 3.02e-03 | 105 | 23 | 2 | C0239946 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 3.61e-03 | 115 | 23 | 2 | EFO_0007878, EFO_0010724 | |
| Disease | Adenocarcinoma | 3.67e-03 | 116 | 23 | 2 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 3.67e-03 | 116 | 23 | 2 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 3.67e-03 | 116 | 23 | 2 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 3.67e-03 | 116 | 23 | 2 | C0205642 | |
| Disease | Carcinoma, Cribriform | 3.67e-03 | 116 | 23 | 2 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 3.67e-03 | 116 | 23 | 2 | C0205641 | |
| Disease | acne | 4.25e-03 | 125 | 23 | 2 | EFO_0003894 | |
| Disease | fatty acid measurement | 4.55e-03 | 436 | 23 | 3 | EFO_0005110 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KGWVHDSIDYRFNHH | 926 | Q9UIG0 | |
| EVYVADGHWHTFLIG | 4296 | Q6V0I7 | |
| AWKTAQEGDHGSHVY | 1131 | P01023 | |
| SYFHGHPEIWHHAND | 256 | Q6UB28 | |
| GLSFEYVWEAAKHDH | 471 | Q8IWU2 | |
| GYHFTADSWEHIHFI | 426 | P49961 | |
| TASHYEDVHWHNSKG | 76 | P55082 | |
| EEMEHYGKWSGGKHH | 581 | O00469 | |
| TSEAHVHVHWYKDGM | 821 | Q5VST9 | |
| VHVHWYKDGMELGHS | 826 | Q5VST9 | |
| WGHEAIEAHGSYFHM | 346 | O00144 | |
| FHVDFGGTSVWYHIH | 211 | Q9Y2K7 | |
| HFTSKHHFGFEAAAW | 226 | P00414 | |
| HFHWGKKHDVGSEHT | 96 | P43166 | |
| GHSAHVTNVRWSHDY | 561 | Q05BV3 | |
| EVHFFDWEEHYSHGL | 86 | O14792 | |
| VIDDAHTDWSKYFHG | 96 | O14994 | |
| VHGYHNWGHRSDTEA | 316 | Q9HAT8 | |
| YDEAIHSVAWHHEGK | 236 | Q5T5C0 | |
| GYGKHNGPEHWHKDF | 6 | P00918 | |
| DGHAAVWHGYEVHGM | 101 | Q96MH6 | |
| VLGAQHFHSGKHYWE | 331 | P19474 | |
| HFHSGKHYWEVDVTG | 336 | P19474 | |
| RKYGGHIGFAAHAHW | 431 | Q2TBF2 | |
| AGHHYWEVRASDHSV | 381 | Q6PJ69 | |
| QKHGEDYNHIHGGKW | 246 | O95922 | |
| DDHGIVFYHWEHVRG | 651 | Q5VV43 |